243 related articles for article (PubMed ID: 15731243)
1. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.
Delos SE; Godby JA; White JM
J Virol; 2005 Mar; 79(6):3488-99. PubMed ID: 15731243
[TBL] [Abstract][Full Text] [Related]
2. Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses.
Melder DC; Pike GM; VanBrocklin MW; Federspiel MJ
J Virol; 2015 Feb; 89(4):2136-48. PubMed ID: 25473063
[TBL] [Abstract][Full Text] [Related]
3. The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.
Earp LJ; Delos SE; Netter RC; Bates P; White JM
J Virol; 2003 Mar; 77(5):3058-66. PubMed ID: 12584331
[TBL] [Abstract][Full Text] [Related]
4. Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor.
Holmen SL; Melder DC; Federspiel MJ
J Virol; 2001 Jan; 75(2):726-37. PubMed ID: 11134286
[TBL] [Abstract][Full Text] [Related]
5. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein.
Gilbert JM; Hernandez LD; Balliet JW; Bates P; White JM
J Virol; 1995 Dec; 69(12):7410-5. PubMed ID: 7494245
[TBL] [Abstract][Full Text] [Related]
6. Identification of glycosylation sites in the SU component of the Avian Sarcoma/Leukosis virus Envelope Glycoprotein (Subgroup A) by mass spectrometry.
Kvaratskhelia M; Clark PK; Hess S; Melder DC; Federspiel MJ; Hughes SH
Virology; 2004 Aug; 326(1):171-81. PubMed ID: 15262505
[TBL] [Abstract][Full Text] [Related]
7. Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth.
Melikyan GB; Barnard RJ; Markosyan RM; Young JA; Cohen FS
J Virol; 2004 Apr; 78(7):3753-62. PubMed ID: 15016895
[TBL] [Abstract][Full Text] [Related]
8. Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.
Ochsenbauer-Jambor C; Delos SE; Accavitti MA; White JM; Hunter E
J Virol; 2002 Aug; 76(15):7518-27. PubMed ID: 12097564
[TBL] [Abstract][Full Text] [Related]
9. A single glycosylation site within the receptor-binding domain of the avian sarcoma/leukosis virus glycoprotein is critical for receptor binding.
Delos SE; Burdick MJ; White JM
Virology; 2002 Mar; 294(2):354-63. PubMed ID: 12009877
[TBL] [Abstract][Full Text] [Related]
10. Substitutions in the receptor-binding domain of the avian sarcoma and leukosis virus envelope uncouple receptor-triggered structural rearrangements in the surface and transmembrane subunits.
Damico R; Rong L; Bates P
J Virol; 1999 Apr; 73(4):3087-94. PubMed ID: 10074159
[TBL] [Abstract][Full Text] [Related]
11. Sequential roles of receptor binding and low pH in forming prehairpin and hairpin conformations of a retroviral envelope glycoprotein.
Matsuyama S; Delos SE; White JM
J Virol; 2004 Aug; 78(15):8201-9. PubMed ID: 15254191
[TBL] [Abstract][Full Text] [Related]
12. A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain.
Melder DC; Yin X; Delos SE; Federspiel MJ
J Virol; 2009 Sep; 83(17):8575-86. PubMed ID: 19515762
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the subgroup A avian sarcoma and leukosis virus putative fusion peptide domain.
Balliet JW; Gendron K; Bates P
J Virol; 2000 Apr; 74(8):3731-9. PubMed ID: 10729148
[TBL] [Abstract][Full Text] [Related]
14. Residue Trp-48 of Tva is critical for viral entry but not for high-affinity binding to the SU glycoprotein of subgroup A avian leukosis and sarcoma viruses.
Zingler K; Young JA
J Virol; 1996 Nov; 70(11):7510-6. PubMed ID: 8892869
[TBL] [Abstract][Full Text] [Related]
15. Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating.
Barnard RJ; Narayan S; Dornadula G; Miller MD; Young JA
J Virol; 2004 Oct; 78(19):10433-41. PubMed ID: 15367609
[TBL] [Abstract][Full Text] [Related]
16. Mutations in Both the Surface and Transmembrane Envelope Glycoproteins of the RAV-2 Subgroup B Avian Sarcoma and Leukosis Virus Are Required to Escape the Antiviral Effect of a Secreted Form of the Tvb
Yin X; Melder DC; Payne WS; Dodgson JB; Federspiel MJ
Viruses; 2019 May; 11(6):. PubMed ID: 31159208
[TBL] [Abstract][Full Text] [Related]
17. The central proline of an internal viral fusion peptide serves two important roles.
Delos SE; Gilbert JM; White JM
J Virol; 2000 Feb; 74(4):1686-93. PubMed ID: 10644338
[TBL] [Abstract][Full Text] [Related]
18. Alpharetrovirus envelope-receptor interactions.
Barnard RJ; Young JA
Curr Top Microbiol Immunol; 2003; 281():107-36. PubMed ID: 12932076
[TBL] [Abstract][Full Text] [Related]
19. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
Netter RC; Amberg SM; Balliet JW; Biscone MJ; Vermeulen A; Earp LJ; White JM; Bates P
J Virol; 2004 Dec; 78(24):13430-9. PubMed ID: 15564453
[TBL] [Abstract][Full Text] [Related]
20. Soluble forms of the subgroup A avian leukosis virus [ALV(A)] receptor Tva significantly inhibit ALV(A) infection in vitro and in vivo.
Holmen SL; Salter DW; Payne WS; Dodgson JB; Hughes SH; Federspiel MJ
J Virol; 1999 Dec; 73(12):10051-60. PubMed ID: 10559319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
